Frontiers in Immunology (Feb 2024)

A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes

  • Albert Rosenberger,
  • Rachel E. Crossland,
  • Ralf Dressel,
  • Dieter Kube,
  • Daniel Wolff,
  • Gerald Wulf,
  • Heike Bickeböller,
  • Anne Dickinson,
  • Ernst Holler

DOI
https://doi.org/10.3389/fimmu.2024.1280876
Journal volume & issue
Vol. 15

Abstract

Read online

IntroductionData on genomic susceptibility for adverse outcomes after hematopoietic stem cell transplantation (HSCT) for recipients are scarce.MethodsWe performed a genome wide association study (GWAS) to identify genes associated with survival/mortality, relapse, and severe graft-versus-host disease (sGvHD), fitting proportional hazard and subdistributional models to data of n=1,392 recipients of European ancestry from three centres.ResultsThe single nucleotide polymorphism (SNP) rs17154454, intronic to the neuronal growth guidant semaphorin 3C gene (SEMA3C), was genome-wide significantly associated with event-free survival (p=7.0x10-8) and sGvHD (p=7.5x10-8). Further associations were detected for SNPs in the Paxillin gene (PXN) with death without prior relapse or sGvHD, as well as for SNPs of the Plasmacytoma Variant Translocation 1 gene (PVT1, a long non-coding RNA gene), the Melanocortin 5 Receptor (MC5R) gene and the WW Domain Containing Oxidoreductase gene (WWOX), all associated with the occurrence of sGvHD. Functional considerations support the observed associations.DiscussionThus, new genes were identified, potentially influencing the outcome of HSCT.

Keywords